Gene · 4287
NIH grants1,882
NIH grants whose papers are about the gene, through NIH's grant-paper links.
41 to 60 of 1,882
Download this page as JSON| Grant | Title | ATXN3 papers | Newest fiscal year |
|---|---|---|---|
| R01HG010169 | Sequence resolution of complex human genome structural variation | 2 | 2025 |
| R01NS027036 | Disease Mechanism and Therapy in TDP-43 Proteinopathies and Dementias | 2 | 2025 |
| R01NS082351 | Understanding the Cellular Basis of Movement Disorders | 2 | 2025 |
| R01NS100529 | Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells | 2 | 2025 |
| R01NS115144 | Genome-Wide Prediction of Dementia in Parkinson's Disease | 2 | 2025 |
| R01NS117539 | Mechanism and effects of communication between actin and gene regulatory complexes | 2 | 2025 |
| R35ES031707 | Chemical Biology of DNA and RNA Alkylation | 2 | 2025 |
| R35GM130393 | Mechanistic studies of chromatin modification in transcription regulation | 2 | 2025 |
| T32AG000114 | Career Training in the Biology of Aging | 2 | 2025 |
| T32AG000255 | Training in age related neurodegenerative diseases | 2 | 2025 |
| T32CA009560 | Carcinogenesis Training Program | 2 | 2025 |
| U54NS123743 | Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets | 2 | 2025 |
| ZIADK033008 | Mechanism of protein quality control at the endoplasmic reticulum | 2 | 2025 |
| D43TW009345 | Northern Pacific Global Health Leadership, Education, and Development for Early-career Researchers (NPGH LEADERs) | 1 | 2025 |
| F31NS137623 | Elucidating the contribution of lipid dysregulation to impaired oligodendrocyte maturation and myelination in Spinocerebellar ataxia type 3 | 1 | 2025 |
| I01BX002211 | Pathogenic soluble aggregated tau as a driver of brain vascular dysfunction in Alzheimer's disease | 1 | 2025 |
| I01BX002466 | VA Biorepository Brain Bank | 1 | 2025 |
| I01BX004146 | Impact of Obesity on Brain Immune Response and Cognition | 1 | 2025 |
| I01CX001702 | Genetic Movement Disorders: Etiologies and Pathogeneses | 1 | 2025 |
| K08NS123552 | Development of a Translational Research Platform to Understand and treat Defective Protein Trafficking in Childhood-Onset Hereditary Spastic Paraplegia | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4287/grants?page=3